Clinical trial
A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without…
NCT00311519 · Halozyme Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00311519 |
|---|---|
| Title | A Phase IIIB Dose Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects |
| Official title | A Phase IIIB Double Blind, Randomized, Placebo-Controlled, Dose-Comparison Study of Subcutaneous Hydration With and Without Human Recombinant Hyaluronidase (HYLENEX) in Volunteer Subjects |
| Lead sponsor | Halozyme Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Hylenex |
| Enrollment | 50 |
| Start date | Nov 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Apr 6, 2006 |
| Last update posted | Apr 6, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: